Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Titel:
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Auteur:
Kunzmann, Volker Siveke, Jens T Algül, Hana Goekkurt, Eray Siegler, Gabriele Martens, Uwe Waldschmidt, Dirk Pelzer, Uwe Fuchs, Martin Kullmann, Frank Boeck, Stefan Ettrich, Thomas J Held, Swantje Keller, Ralph Klein, Ingo Germer, Christoph-Thomas Stein, Hubert Friess, Helmut Bahra, Marcus Jakobs, Ralf Hartlapp, Ingo Heinemann, Volker